Parkinson's Disease (PD) related Cell Products
Since conventional treatments like deep brain stimulation and dopamine replacement therapy can only reduce symptoms and not cure Parkinson's disease (PD), which is a common neurodegenerative disease whose primary pathological feature is the degeneration and death of dopaminergic neurons in the brain's substantia nigra, research into novel treatments—particularly cell-based therapies—has become crucial.
In vitro cell models play an important role in the study of PD. Common in vitro cell models include non-neuronal tumor cell lines, neuronal tumor cell lines, and cell models derived from induced pluripotent stem cells (iPSCs). These models provide important tools for studying the pathogenesis of Parkinson's disease and for drug screening.
At Creative Biolabs, our team has successfully developed human pluripotent stem cell-derived neuron products based on iPSC technology after years of research. In vitro, these cells can be made to develop into either glutamatergic or dopaminergic neurons. Validation data demonstrate the long-term stability and functionality of iPSC-derived dopaminergic neurons in terms of dopamine production and release, thus ensuring the maintenance of motor function.
Please feel free to browse through our related products list to discover the ideal tools for your PD research. For more information about our products or pricing, please contact us.
Explore PD Models Based on Your Research Objective
Alpha-synuclein (α-syn) is a protein that is abundant in the brain, particularly in presynaptic terminals. It is involved in maintaining synaptic function under normal circumstances, but in PD, misfolding and aggregation of α-syn is a major cause of neurodegenerative changes.
Cat. No | Product Name |
---|---|
NCL2110P209 | Green Fluorescent Alpha-synuclein SH-SY5Y Cell Line |
NCL2110P356 | Synuclein A53T Overexpressed SH-SY5Y Cell Line |
NCL2110P213 | Green Fluorescent Alpha-synuclein U2OS Cell Line |
NCL2110P208 | Alpha-synuclein Stable Cell Lines |
Mutations in the LRRK2 gene are one of the major genetic factors for PD, especially mutations such as G2019S and R1441C, which are highly associated with late-onset PD. These mutations are usually inherited in an autosomal dominant manner and can lead to increased LRRK2 kinase activity, resulting in neurotoxic effects.
Cat. No | Product Name |
---|---|
NCL-2101-ZP15 | iNeuTM Human Neural Stem Cells, LRRK2 G2019S HET |
NCL-2101-ZP14 | iNeuTM Human Neural Stem Cells, LRRK2 G2019S HOM |
Parkin maintains mitochondrial quality control in cells by recognizing damaged mitochondria and promoting their autophagy. This mechanism is critical for neuronal survival, as mitochondrial dysfunction is a key feature of PD. Parkin is also involved in the ubiquitination and degradation of α-synuclein, which is closely associated with the pathological features of PD.
Cat. No | Product Name |
---|---|
NCL2110P248 | Parkin Mitochondrial Recruitment Assay Cell Line |
NCL2110P234 | Parkin Mitochondrial Recruitment Assay Cell Line [Parkinson's Disease (PD) Model] |
The treatment of PD is still full of challenges, but through innovative application research of cell therapy, we are gradually approaching the goal of curing this disease. We recommend our related products and demonstrate our expertise and technical strength in the field of cell therapy. In the future, we look forward to working with more researchers to jointly promote the development of PD treatment.
- iNeuMab™ Anti-SEZ6 Antibody (NRP-0422-P517) (Cat#: NRP-0422-P517)
- iNeuMab™ Anti-EPHB2 Antibody (NRP-0422-P1220) (Cat#: NRP-0422-P1220)
- iNeuMab™ Anti-CD32b Antibody (NRP-0422-P1803) (Cat#: NRP-0422-P1803)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Anti-CD20 Antibody (NRP-0422-P1230) (Cat#: NRP-0422-P1230)
- iNeuMab™ Anti-Alpha Synuclein BBB Shuttle Antibody (NRZP-1022-ZP4050) (Cat#: NRZP-1022-ZP4050)
- iNeuMab™ Anti-Tau Antibody (NRP-0422-P2293) (Cat#: NRP-0422-P2293)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- iNeuMab™ Anti-FGFR1 Antibody (NRP-0422-P1244) (Cat#: NRP-0422-P1244)
- iNeuMab™ Anti-GARP Antibody (NRP-0422-P1639) (Cat#: NRP-0422-P1639)
- iNeu™ Human Schwann Cell (Cat#: NCL-2103-P63)
- iNeu™ Human Oligodendrocyte Progenitor Cells (OPCs) (Cat#: NCL-2103-P49)
- Rat Microglia Cell Line HAPI, Immortalized (Cat#: NCL2110P015)
- Human Dental Pulp Stem Cells (Cat#: NRZP-1122-ZP113)
- iNeu™ Human Motor Neurons (Cat#: NCL-2103-P71)
- iNeu™ Human Sensory Neurons (Cat#: NCL-2103-P62)
- Mouse Retinal Ganglion Cell Line RGC-5 (Cat#: NCL2110P154)
- Green Fluorescent Tau cell Line (Cat#: NCL2110P219)
- Mouse Glioma Cell Line GL261-GFP (Cat#: NCL-2108P04)
- Human Neurons Isolated from Cortex (Cat#: NCL-21P6-023)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- AAV2/9-hEF1a-fDIO-eNpHR 3.0-mCherry-WPRE-pA (Cat#: NTA-2012-ZP78)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Tau Antisense Oligonucleotide (IONIS-MAPTRx) (Cat#: NV-2106-P29)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Human presenilin 1 (PSEN1), transcript variant 2 (NM_007318) ORF clone, TurboGFP Tagged (Cat#: NEP-0421-R0140)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroPro™ Anti-SGSH BBB Shuttle Protein (Cat#: NRZP-0423-ZP505)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-NAGLU BBB Shuttle Protein (Cat#: NRZP-0423-ZP506)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)